News & Insights

Why we’re overweight healthcare

October 31, 2025

Time to Read: 3:08 mins

In this video, BNY Investments Newton global income portfolio manager, Jon Bell discusses some of the reasons for overweighting healthcare despite the sector’s recent challenges.

Key points:

Demographics are driving rising healthcare spending and innovation remains crucial for managing costs and improving outcomes.
The BNY Mellon Global Equity Income strategy is at its highest-ever healthcare overweight, focusing on medical devices, equipment, hospitals and insurers.
As Covid claims decline, insurers have been able to raise prices to achieve margin gains.

2753750 Exp: 26 January 2026

IFMH | Fixed Income

Assessing Europe's labelled bond market

In this video, Fabien Collado, portfolio manager of the Responsible Horizons Euro Corporate Bond strategy, shares his thoughts on the evolution of labelled bonds in Europe and explains why robust due diligence is integral to spotting and validating opportunities

Article | Equities

Novo Nordisk: rethinking the playbook

Direct-to-client (DTC) health platforms and personalized compounded treatments may become standard practice in the rapidly evolving obesity treatment market. Walter Scott investment analyst Dr Oriana Beaumont believes that Novo Nordisk’s recent changes will help position them to effectively compete in this exciting and vast market.

IFMH | Equities

Google's AI search issue

In this video, Walter Scott client investment manager George Dent uses Google as a case study to highlight the potential profitability issues facing companies that run artificial intelligence (AI)-driven search functions.

Article | Equities

Global Equity Income: over and underweights

Jon Bell, global income portfolio manager at BNY Investments Newton, discusses the largest over and underweight positions in the BNY Mellon Global Equity Income portfolio.